INNOVUS PHARMACEUTICALS, INC. Finite-Lived Intangible Assets, Net
INNOVUS PHARMACEUTICALS, INC. had Finite-Lived Intangible Assets, Net of $3.38 million as of 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2019-11-14
- 2019-09-30: Finite-Lived Intangible Assets, Net $3.38M.
- 2019-06-30: Finite-Lived Intangible Assets, Net $3.56M.
- 2019-03-31: Finite-Lived Intangible Assets, Net $3.74M.
- 2018-12-31: Finite-Lived Intangible Assets, Net $3.89M.
| Period end | Finite-Lived Intangible Assets, Net |
|---|---|
| 2019-09-30 | $3.38M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $3.56M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $3.74M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $3.89M 10-Q · filed 2019-11-14 |
| 2018-09-30 | $3.80M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $3.96M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $4.12M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $4.27M 10-K · filed 2019-04-01 |
| 2017-09-30 | $4.43M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $4.59M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $4.75M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $4.90M 10-K · filed 2018-04-02 |
| 2016-09-30 | $5.40M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $5.58M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $5.76M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $5.30M 10-Q · filed 2016-11-14 |
| 2015-09-30 | $5.46M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $5.61M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $5.76M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $1.06M 10-K · filed 2016-03-30 |
| 2014-09-30 | $1.04M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $1.06M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $1.10M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $1.11M 10-K · filed 2014-03-28 |